PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9

Despite the advance in medications in the past decade, aggressive breast cancer such as triple-negative breast cancer is difficult to treat. Here, we examined a counter-intuitive approach to converting human bone marrow-derived mesenchymal stem cells (MSCs) into induced tumor-suppressing cells by ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xun, Li, Kexin, Aryal, Uma K., Li, Bai-Yan, Yokota, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420348/
https://www.ncbi.nlm.nih.gov/pubmed/36090473
http://dx.doi.org/10.1016/j.omto.2022.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420348/
https://www.ncbi.nlm.nih.gov/pubmed/36090473
http://dx.doi.org/10.1016/j.omto.2022.08.003

Ejemplares similares